Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Hospira, Inc.    HSP

SummaryQuotesNewsAnalysisCalendarCompanyFinancialsConsensus 
News SummaryMost relevantAll newsSector news 
Latest news on HOSPIRA, INC.
2015 HOSPIRA : Announces First Installation of Plum 360™ Infusion System With H..
2015 HOSPIRA : Announces First Installation of Plum 360(TM) Infusion System With Hosp..
2015DJPFIZER : Buy of Hospira Gets Green Light
2015DJPFIZER : Gets U.S. Approval to Acquire Hospira, With Divestitures
2015 HOSPIRA : Expert committee BACKS Hospira’s InflectraTM
2015 HOSPIRA : Charleston Area Medical Center Integrates Smart Pump Technology to Adv..
2015 HOSPIRA : TGA Approves First mAb Biosimilar
2015 HOSPIRA : Applauds UK's NICE for Issuing Adoption Resource to Help Drive the Int..
2015DJPFIZER : Gets EU Green Light for Hospira Merger
2015 HOSPIRA : Pfizer wins EU approval for $15 billion Hospira buy
2015DJPFIZER : Hospira Merger Gets EU Green Light
2015DJHOSPIRA : Earnings Beat on Strength in Specialty Injectables -- Update
2015DJHOSPIRA : Earnings Beat on Strength in Specialty Injectables
2015DJMerck Earnings Hurt by Arthritis Drug Knockoffs
2015DJPFIZER : Boosts Its Earnings Outlook -- Update
2015DJPFIZER : Boosts Its Earnings Outlook
2015DJPFIZER : Boosts Its Earnings Outlook
2015 Mylan independence from Teva's embrace comes with a price
2015 HOSPIRA : Announces U.S. Launch of Generic Bivalirudin for Injection
2015 HOSPIRA : to Announce Second-Quarter 2015 Results on July 29, 2015
2015 HOSPIRA : Pfizer offers concessions in bid to win EU okay for Hospira deal
2015 Exclusive - Hospira wins French biosimilar drug tender at 45 percent discount
2015 HOSPIRA : New results from first real-world study show comparable effectiveness ..
2015 HOSPIRA : New results from first real-world study show comparable effectiveness ..
2015 HOSPIRA : ANVISA Approves First Infliximab Biosimilar in Brazil
2015 HOSPIRA : Alliance for Health Reform Bring Food and Drug Administration, Industr..
2015DJPFIZER : Receives Second Request From FTC
2015DJPFIZER : Receives Second Request From FTC Over Hospira Deal
2015 HOSPIRA : Shareholders Approve Merger of Hospira and Pfizer at Special Meeting
2015 Alexion to bolster rare disease offering with $8.4 billion deal
2015 HOSPIRA : Statement On FDA's Final Biosimilar Guidance Documents
2015DJPFIZER : Trims Outlook on Stronger Dollar -- Update
2015DJHOSPIRA : Profit Easily Tops Expectations as Injectables Remain Strong
2015DJPFIZER : Merck and Bristol-Myers Squibb Report Solid Results
2015DJPFIZER : Trims Outlook on Stronger Dollar
2015 HOSPIRA : Leadership Presents at Preeminent European Biosimilars Forum, Announce..
2015 Banks see talent flee amid healthcare M&A boom
2015 HOSPIRA : Hope for Greater Access for Patients to Biosimilar Medicines
2015 Generic drugmaker Mylan offers $29 billion for Perrigo
2015 HOSPIRA : to Announce First-Quarter 2015 Results on April 28, 2015
2015DJHOSPIRA : Gets Warning Letter on Quality Issues at Italy Plant
2015 HOSPIRA : INFLECTRA(TM) (Infliximab) Now Available in Canada
2015 HOSPIRA : Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates..
2015 HOSPIRA : Inflectra™ (infliximab) patient registry reports interim results..
2015 HOSPIRA : Statement on FDA Approval of the First Biosimilar in the United States
2015 AbbVie boosts cancer drug pipeline with $21 billion Pharmacyclics deal
2015 Biotech buys get pharma M&A off to flying start in 2015
2015 AbbVie boosts cancer drug pipeline with $21 billion Pharmacyclics deal
2015DJGeneric Copies of Remicade Go on Sale in Europe
2015 Biosimilar copies of blockbuster drug launch in major EU markets
2015 HOSPIRA : Inflectra(TM) (infliximab) patient registry reports interim results in..
2015 HOSPIRA : SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of B..
2015 HOSPIRA : SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of..
2015 HOSPIRA : launches first biosimilar monoclonal antibody (mAb) Inflectra™ (..
2015 HOSPIRA : launches first biosimilar monoclonal antibody (mAb) Inflectra(TM) (inf..
2015DJHOSPIRA : Painkiller in Short Supply Following Hospira Recall -- Update
2015DJHOSPIRA : Profit Tops Expectations on Injectables Strength
2015 HOSPIRA : Reports Fourth-Quarter and Full-Year 2014 Results
2015 HOSPIRA : SHAREHOLDER ALERT: The Law Offices of Vincent Wong Commences an Invest..
2015 HOSPIRA : SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of B..
2015 HOSPIRA : SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Pr..
2015 HOSPIRA : Acquisition By Pfizer Inc. May Not Be In The Best Interest of HSP Shar..
2015 HOSPIRA : Pfenex And Hospira Announce Collaboration To Develop And Commercialize..
2015 HOSPIRA : Harwood Feffer LLP : Announces Investigation of Hospira, Inc.
2015 HOSPIRA : Cancels Previously Scheduled Conference Call to Discuss Fourth-Quarter..
2015 HOSPIRA : Stockholders Encouraged to Contact Securities Law Firm about Takeover
2015 HOSPIRA : UPDATE - INVESTOR ALERT: Levi & Korsinsky, LLP Launches an Investigati..
2015 HOSPIRA : SHAREHOLDER ALERT: The Law Offices of Vincent Wong Launches an Investi..
2015 HOSPIRA : SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Pr..
2015 HOSPIRA : Ryan & Maniskas, LLP : Announces Investigation of Hospira Inc.
2015 HOSPIRA : INVESTOR ALERT: Levi & Korsinsky, LLP Commences an Investigation of th..
2015 HOSPIRA : Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Invest..
2015 Pfizer to buy Hospira for $15 billion to bolster hospital products
2015 Pfizer's Hospira deal bets on price spike for specialty generics
2015 HOSPIRA : Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf ..
1  2  3  4  5Next
Advertisement
Income Statement Evolution
More Financials
Managers
NameTitle
F. Michael Ball Chief Executive Officer & Director
John C. Staley Non-Executive Chairman
Matthew R. Stober Senior Vice President-Operations
Thomas E. Werner Chief Financial Officer & Senior Vice President
Sumant Ramachandra Chief Scientific Officer & Senior Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
HOSPIRA, INC.0.00%0
SUN PHARMACEUTICAL IND..-13.59%23 663
OTSUKA HOLDINGS CO LTD4.59%22 290
ONO PHARMACEUTICAL CO...-44.11%12 538
ASPEN PHARMACARE HOLDI..-10.55%9 123
SHANGHAI FOSUN PHARMAC..-1.62%8 071
More Results